GZERO Media logo
{{ subpage.title }}

New "Japan In :60" limited series:  What the world can learn from Japan’s pandemic response

As the COVID pandemic rages across the world, some nations have done better than others in both public health response and economic recovery. One bright spot has been Japan -- despite having the oldest population and economic challenges prior to the global crisis, the country has ranked among the very lowest in the G7 in terms of mortality rates and GDP decline.

In a new limited video series, "Japan In 60 Seconds," presented by GZERO Media in partnership with the Consulate General of Japan, the GZERO team will explore the reasons why, talking with leading experts and officials from Japan and beyond. What can the world learn from Japan's pandemic response? One key lesson is that no nation is truly an island.

The kickoff to the series offers a brief overview of pandemic response in Japan —from early lessons learned, to public health campaigns and infrastructure that have made Japan an example for the world.

This video is sponsored by the Consulate General of Japan.

Uncertainties of COVID vaccine rollout timing; US-Russia under Biden

Ian Bremmer shares his perspective on global politics on this week's World In (More Than) 60 Seconds:

Number one, what will COVID vaccine distribution look like in the United States and elsewhere?

Very politicized, right? I mean, the fact is that there's an effort to have a distribution to medium and low-income countries. $38 billion requested, one fourth funded at this point. It is so obvious we desperately need it. The money is not yet there. It's clear that the emerging markets are going to take a lot longer and the poorest countries are going to take a lot longer to get vaccines. Now, at least that's less of a disaster in some countries with very, very young people because it's all asymptomatic spread, very few people are actually dying or getting sick from coronavirus if you're in, let's say, a Sub-Saharan African country where the average age is 17 or 18.

Read Now Show less

A Shot in the Arm: Moderna’s Co-Founder on the COVID-19 Vaccine

The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On GZERO World, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.

Podcast: COVID Vaccine in Record Time - What Now? Moderna Co-Founder Noubar Afeyan

Listen: The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On the GZERO World podcast, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.

GZERO Summit: Fighting COVID-19

Almost one year since the coronavirus upended the world, what's the current state of play on ending the pandemic, and what challenges we face towards vaccinating everyone in 2021.

Fortunately, as the virus has grown exponentially, so has science, Dr. Larry Brilliant, CEO of Pandefense and one of the world's most highly regarded epidemiologists, said during the panel discussion on fighting COVID-19 at the 2020 GZERO Summit in Japan.

Read Now Show less

Latest